This paper is in the following e-collection/theme issue:

Pilot studies (non-ehealth) (58) New Methods (911) Decision Support for Health Professionals (1145) Development and Evaluation of Research Methods, Instruments and Tools (439)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48057, first published .
Evaluation of a Portable Blood Gas Analyzer for Prehospital Triage in Carbon Monoxide Poisoning: Instrument Validation Study

Evaluation of a Portable Blood Gas Analyzer for Prehospital Triage in Carbon Monoxide Poisoning: Instrument Validation Study

Evaluation of a Portable Blood Gas Analyzer for Prehospital Triage in Carbon Monoxide Poisoning: Instrument Validation Study

Authors of this article:

Matthieu Lyon1 Author Orcid Image ;   Christophe Alain Fehlmann1, 2 Author Orcid Image ;   Marc Augsburger3 Author Orcid Image ;   Thomas Schaller1 Author Orcid Image ;   Catherine Zimmermann-Ivol4 Author Orcid Image ;   Julien Celi1 Author Orcid Image ;   Birgit Andrea Gartner1 Author Orcid Image ;   Nicolas Lorenzon4 Author Orcid Image ;   François Sarasin1 Author Orcid Image ;   Laurent Suppan1 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

    Original Paper

    1Division of Emergency Medicine, Department of Anesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland

    2School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada

    3Unit of Forensic Toxicology and Chemistry, University Center of Legal Medicine, Lausanne-Geneva, Switzerland

    4Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

    Corresponding Author:

    Laurent Suppan, MD

    Division of Emergency Medicine

    Department of Anesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine

    University of Geneva Hospitals and Faculty of Medicine

    Rue Gabrielle-Perret-Gentil 4

    Geneva, 1211

    Switzerland

    Phone: 41 223723311

    Email: laurent.suppan@hcuge.ch


    Background: Carbon monoxide (CO) poisoning is an important cause of morbidity and mortality worldwide. Symptoms are mostly aspecific, making it hard to identify, and its diagnosis is usually made through blood gas analysis. However, the bulkiness of gas analyzers prevents them from being used at the scene of the incident, thereby leading to the unnecessary transport and admission of many patients. While multiple-wavelength pulse oximeters have been developed to discriminate carboxyhemoglobin (COHb) from oxyhemoglobin, their reliability is debatable, particularly in the hostile prehospital environment.

    Objective: The main objective of this pilot study was to assess whether the Avoximeter 4000, a transportable blood gas analyzer, could be considered for prehospital triage.

    Methods: This was a monocentric, prospective, pilot evaluation study. Blood samples were analyzed sequentially with 2 devices: the Avoximeter 4000 (experimental), which performs direct measurements on blood samples of about 50 µL by analyzing light absorption at 5 different wavelengths; and the ABL827 FLEX (control), which measures COHb levels through an optical system composed of a 128-wavelength spectrophotometer. The blood samples belonged to 2 different cohorts: the first (clinical cohort) was obtained in an emergency department and consisted of 68 samples drawn from patients admitted for reasons other than CO poisoning. These samples were used to determine whether the Avoximeter 4000 could properly exclude the diagnosis. The second (forensic) cohort was derived from the regional forensic center, which provided 12 samples from documented CO poisoning.

    Results: The mean COHb level in the clinical cohort was 1.7% (SD 1.8%; median 1.2%, IQR 0.7%-1.9%) with the ABL827 FLEX versus 3.5% (SD 2.3%; median 3.1%, IQR 2.2%-4.1%) with the Avoximeter 4000. Therefore, the Avoximeter 4000 overestimated COHb levels by a mean difference of 1.8% (95% CI 1.5%-2.1%). The consistency of COHb readings by the Avoximeter 4000 was excellent, with an intraclass correlation coefficient of 0.97 (95% CI 0.93-0.99) when the same blood sample was analyzed repeatedly. Using prespecified cutoffs (5% in nonsmokers and 10% in smokers), 3 patients (4%) had high COHb levels according to the Avoximeter 4000, while their values were within the normal range according to the ABL827 FLEX. Therefore, the specificity of the Avoximeter 4000 in this cohort was 95.6% (95% CI 87%-98.6%), and the overtriage rate would have been 4.4% (95% CI 1.4%-13%). Regarding the forensic samples, 10 of 12 (83%) samples were positive with both devices, while the 2 remaining samples were negative with both devices.

    Conclusions: The limited difference in COHb level measurements between the Avoximeter 4000 and the control device, which erred on the side of safety, and the relatively low overtriage rate warrant further exploration of this device as a prehospital triage tool.

    JMIR Form Res 2023;7:e48057

    doi:10.2196/48057

    Keywords

    carbon monoxide poisoning; carbon monoxide intoxication; prehospital triage; Avoximeter 4000; CO-oximetry; blood gas; blood work; pulse oximeter; cohort study; carbon monoxide; poisoning; sensor; triage tool; triage; oximeter; pilot study; medical device 


    Carbon monoxide (CO) poisoning is a leading cause of death, morbidity, and cost by poisoning worldwide [1]. It is classically encountered in winter, in enclosed spaces, and with any kind of combustion [2-4]. Symptoms are mostly aspecific, making CO poisoning difficult to identify. There can be gastrointestinal (nausea, vomiting, and abdominal pain), cardiopulmonary (dyspnea, chest pain, and syncope), and neurologic (headache, visual disturbance, ataxia, dizziness, delirium, coma, and seizures) manifestations that cannot be integrated into a specific toxidrome [2,3,5,6]. The diagnosis of CO poisoning is usually made by establishing high levels of carboxyhemoglobin (COHb) through blood gas analysis [7]. Medical management consists in enhancing CO clearance by exposure removal, supportive treatment, and above all, oxygenotherapy [3,8].

    In most clinical settings, COHb levels are precisely and accurately determined by blood CO-oximetry through automated differential spectrophotometry; unfortunately, the bulkiness of regular blood gas analyzers prevents them from being used in the prehospital setting [7]. This drawback is noteworthy since fires—and more generally any incident potentially causing CO poisoning—can lead to multiple-casualty incidents [9-11]. In such situations, the stress caused by the fire and by the evacuation can generate aspecific symptoms akin to those of CO poisoning [12]. This can lead to the unnecessary transport and emergency department (ED) admission of many patients to rule out CO poisoning and can therefore potentially overload the regional health care system. A reliable tool for assessing COHb levels at the scene could therefore improve prehospital triage and maximize resources by preventing both pre- and in-hospital systems overload.

    The current diagnostic tools adapted for prehospital use present many limitations that are partly conditioned by an imperative of transportability. Conventional pulse oximeters do not discriminate COHb from oxyhemoglobin (O2Hb) and display falsely reassuring oxygen saturation (SpO2) levels even in severe CO poisoning cases [13]. This is explained by the fact that most pulse oximeters only use 2 wavelengths to discriminate O2Hb from reduced hemoglobin (usually 660 and 930-940 nm) and that O2Hb and COHb present similar light absorption patterns at these wavelengths [14,15]. To overcome this limitation, multiple-wavelength pulse oximeters have been developed to better discriminate the light absorption patterns of O2Hb, COHb, reduced hemoglobin, and methemoglobin [14]. However, these devices are far from reliable even under ideal testing conditions [16-28]. Moreover, the reliability of many medical instruments in the prehospital setting, where hostile conditions such as lighting, excessive movements, and temperature can markedly influence monitoring, is debatable [29,30]. Indeed, there is little data regarding the reliability of pulse CO-oximetry in this context.

    Since even regular pulse oximeters are prone to failures and inaccuracies in the prehospital setting, reliable and transportable devices using discrimination techniques akin to those of regular blood gas analyzers could prove useful to manage major incidents with potential CO poisoning victims [31-33]. To avoid unnecessary transports and admission, the principal objective of this pilot study was to assess whether the Avoximeter 4000 (Werfen), an on-site transportable blood gas analyzer, provided reliable COHb measurements in a population of adult patients a priori not intoxicated to CO, thus providing values near to the diagnostic thresholds used in clinical practice. The secondary objectives of this study were to determine if this analyzer provided accurate COHb measurements in forensic samples of proven CO poisoning cases as well as according to clinical thresholds commonly used in clinical practices.


    Study Design and Setting

    This was a monocentric, prospective pilot evaluation study carried out at the ED of the Geneva University Hospitals. We compared blood samples sequentially with 2 blood gas analyzers (one being tested and the other serving as a gold standard) in 2 different cohorts. Forensic samples were analyzed in August 2019, and samples were collected from live patients between June and August 2022. The results were then recorded immediately without any personal authentication data (apart from age and gender) in a digital Excel sheet (Microsoft Excel, version 2013; Microsoft Corporation).

    Ethical Considerations

    Consent was waived by the regional ethics committee (Commission Cantonale d’Ethique de la Recherche CCER project-ID 2019-01048) since only already drawn blood samples were used for the purpose of this study. Since only residuals from blood samples already drawn for clinical purposes were used, the ethics committee waived the need for consent, thereby also preventing any kind of compensation. In addition, there was no contact between the patients from whom the blood was drawn and the investigators. Patient confidentiality was guaranteed by the fact that no identifying information was ever even asked for, let alone recorded.

    Blood Gas Analyzers

    The ABL827 FLEX blood gas analyzer (Radiometer) was used as the gold standard. This blood gas, oximetry, electrolyte, and metabolite analyzer is a complex modular device composed of several units, one of which is dedicated to oximetry studies. This unit measures COHb levels through an optical system composed of a 128-wavelength spectrophotometer. This optical system, which was already used in prior models, was validated using gas chromatography. The ABL827 FLEX is routinely used in the ED, and internal quality controls are carried out twice a day. In addition, 4 external quality controls are carried out every year.

    The Avoximeter 4000 is a blood oximeter that performs hemoglobin, O2Hb, COHb, and methemoglobin direct measurements on blood samples of about 50 µL by analyzing light absorption at 5 different wavelengths. The drawn blood is injected into a single-use cuvette, which is inserted into the device. Results are delivered in 7 to 10 seconds. This device can easily be transported by virtue of its reasonable size (20.3 cm×25.4 cm×9.5 cm) and weight (1.8 kg). The accuracy and precision claimed by the manufacturer are ±2% and 1%, respectively.

    An Avoximeter 4000 as well as 100 cuvettes were provided free of charge by Axon Lab AG for the purpose of this study. Quality controls were performed according to the manufacturer’s instructions throughout the study period.

    Blood Samples

    Blood samples were collected from a cohort of 68 adult patients aged 18 years or older admitted to the ED of the Geneva University Hospitals between June and August 2022. None of these patients was admitted for CO poisoning. There were no exclusion criteria. The samples were collected from patients who required blood gas analysis through the usual ABL827 FLEX analyzer for their own clinical management. Residuals are almost always present in the syringes, and 50 µL of the remaining blood samples were therefore immediately used to perform the analysis on the Avoximeter 4000 device. The majority were of venous origin (n=55, 81%), and the rest were arterial (n=13, 19%). These samples were meant to evaluate if the tested CO-oximeter could properly exclude the diagnosis.

    The second cohort was derived from the regional forensic center (Centre Universitaire Romand de Médecine Légale, the French-speaking Swiss university center of forensic medicine), which provided 12 samples from documented CO poisoning that were analyzed by the 2 methods on August 8, 2019; this group was meant to assess the ability of the Avoximeter 4000 to identify CO poisoning cases.

    Data Collection and Outcomes

    All specimens were sequentially analyzed with the ED blood gas analyzer (ABL827 FLEX) and the point-of-care CO-oximeter (Avoximeter 4000) to compare COHb levels. A subset of samples from the cohort of ED patients (n=8, 11%) were analyzed several times with the Avoximeter 4000 to estimate the intraindividual consistency of the device.

    The primary outcome was the difference in the measure of COHb (in percentage) between the 2 devices. Secondary outcomes were the reliability of the measure with the Avoximeter 4000 and the overtriage rate of the Avoximeter 4000 when applying the diagnostic thresholds used in common clinical practice (<5% for nonsmokers and <10% for smokers) [8,24]. In the forensic cohort, the smoking status was unknown, and a diagnostic threshold of 5% was therefore applied to all samples.

    Data Analysis

    Stata (version 17.0; StataCorp LLC) was used for statistical analysis. First, a quantitative analysis with the Bland-Altman diagrams as a measure of agreement was performed. Then, positive and negative results were defined according to the aforementioned diagnostic thresholds. This allowed to determine the overtriage rate and the Avoximeter 4000’s specificity. To assess the reliability of the Avoximeter 4000 through repeated measurements, an intraclass correlation coefficient was computed.


    Patients

    The median age of the patients in the live sample cohort (n=68) was 64.5 (IQR 42.5-82) years. There were 22 (32%) active smokers. These patients were admitted because of neurologic (n=20, 29%), cardiorespiratory (n=19, 28%), gastrointestinal (n=9, 13%), and traumatological (n=8, 12%) problems.

    Primary Outcome

    The mean COHb level in the clinical cohort was 1.7% (SD 1.8%; median 1.2%, IQR 0.7%-1.9%) with the ABL827 FLEX versus 3.5% (SD 2.3%; median 3.1%, IQR 2.2%-4.1%) with the Avoximeter 4000. Therefore, the Avoximeter 4000 overestimated COHb levels by a mean difference of 1.8% (95% CI 1.5%-2.1%). The agreement between the measures provided by these devices is shown in Figure 1.

    ‎
    Figure 1. Bland-Altman plots featuring differences in COHb between the Avoximeter 4000 and the ABL827 Flex (Avox-ABL) blood gas analyzers according to mean values. (A) Live samples and (B) forensic specimens. COHb: carboxyhemoglobin.

    The consistency of COHb readings by the Avoximeter 4000 is presented in Figure 2. The correlation of measurements made on the same individual was excellent, with intraclass correlation coefficient of 0.97 (95% CI 0.93-0.99).

    ‎
    Figure 2. Correlation between different measurements carried out on the same 8 blood samples. COHb: carboxyhemoglobin.

    Secondary Outcomes

    Clinical Cohort

    Using the prespecified cutoffs (5% in nonsmokers and 10% in smokers), 3 patients (4%) had high COHb levels according to the Avoximeter 4000, while their values were within the normal range according to the ABL827 FLEX. Therefore, the specificity of the Avoximeter 4000 in this cohort was 95.6% (95% CI 87%-98.6%), and the overtriage rate would have been 4.4% (95% CI 1.4%-13%). The sensitivity cannot be estimated in this clinical cohort due to the absence of a true positive test for CO poisoning.

    Forensic Cohort

    Regarding the forensic samples, 10 of 12 (83.3%) samples were positive with both devices, while the 2 remaining samples were negative with both devices. Theoretically, this would represent a sensitivity of 100%, but these results should be interpreted with great caution given the limited sample size and the origin of these samples.


    Principal Findings

    In this study, the Avoximeter 4000, an on-site transportable blood gas analyzer, provided reliable COHb measurements in a population of adult patients admitted to an ED for reasons other than CO poisoning.

    Overall, the Avoximeter 4000 generally led to a mild overestimation of COHb levels. The difference found between COHb values was limited and erring on the side of safety, which is undeniably preferable in this setting. In addition, the rate of overtriage, which was less than 5%, is probably acceptable for most prehospital systems. Indeed, overtriage is probably higher if triage is only based on potential CO poisoning symptoms given their aspecific nature.

    The difference in COHb levels was higher in forensic specimens. This could be either due to the very nature of these specimens, to less accurate measurements with higher COHb concentrations, or both. Regardless of the reasons underlying this discrepancy, the differences reported in this study would not have altered the clinical management of such patients since there was a good agreement according to the diagnostic thresholds used in practice.

    The main limitation of this study is the lack of CO poisoning samples from living patients, which made it impossible to estimate the sensitivity of this device in this population. This was however mitigated by the inclusion of the forensic samples.

    Another limitation is the fact that the assessment was carried out in an ED rather than in the field. However, the bulk of the device and the quick acquisition of the results once samples have been collected all support further evaluation in the prehospital environment.

    The encouraging results reported here support further assessment of the Avoximeter 4000 as a potential prehospital triage tool in case of CO poisoning. It could be especially useful in a large-scale event to avoid overloading hospital systems without compromising patient safety by virtue of a reasonable false negative rate. This could also limit costs and save resources by turning what is currently a hospital triage logic into a prehospital one.

    Thus, this pilot study lays the ground for a full-fledged prehospital study. Such a study will certainly take time since fires are unpredictable events, and researchers will need to be able to respond round the clock. The potential benefits are undoubtedly worth the effort since increasing on-site triage efficiency and avoiding unnecessary transports to the hospital could help decrease ED overcrowding, which represents a challenging and critical public health issue.

    Conclusions

    This pilot assessment showed a good correlation between the Avoximeter 4000 and the gold standard blood gas analyzer regarding COHb levels. By somewhat erring on the safe side, the Avoximeter 4000 would have led to a 4.4% overtriage rate in a real setting. This portable CO-oximeter should now be tested in the field to assess its actual yield in case of a major incident with potential CO poisoning.

    Acknowledgments

    The authors extend their warmest thanks to the Centre Universitaire Romand de Médecine Légale for their help in acquiring the forensic samples and to Mr Pierre Bruchez from Axon Lab AG, who provided them with the Avoximeter 4000 device and the cuvettes.

    Data Availability

    The data sets generated and analyzed during this study are available from the corresponding author on reasonable request.

    Authors' Contributions

    ML, BAG, JC, MA, and LS conceptualized the study. ML, TS, LS, MA, NL, and JC defined the methodology and carried out the investigation. ML, CAF, and LS participated in data curation. CAF performed the formal analysis and visualization. LS was in charge of project administration. FS and LS supervised the project. ML, CAF, and LS drafted the original paper, which was reviewed and approved by all authors.

    Conflicts of Interest

    None declared.

    1. Ran T, Nurmagambetov T, Sircar K. Economic implications of unintentional carbon monoxide poisoning in the United States and the cost and benefit of CO detectors. Am J Emerg Med. 2018;36(3):414-419. [FREE Full text] [CrossRef] [Medline]
    2. Marchewka J, Gawlik I, Dębski G, Popiołek L, Marchewka W, Hydzik P. Cardiological aspects of carbon monoxide poisoning. Folia Med Cracov. 2017;57(1):75-85. [FREE Full text] [Medline]
    3. Ng PCY, Long B, Koyfman A. Clinical chameleons: an emergency medicine focused review of carbon monoxide poisoning. Intern Emerg Med. 2018;13(2):223-229. [CrossRef] [Medline]
    4. Kinoshita H, Türkan H, Vucinic S, Naqvi S, Bedair R, Rezaee R, et al. Carbon monoxide poisoning. Toxicol Rep. 2020;7:169-173. [FREE Full text] [CrossRef] [Medline]
    5. Roth D, Krammel M, Schreiber W, Herkner H, Havel C, Laggner AN. Unrecognized carbon monoxide poisoning leads to a multiple-casualty incident. J Emerg Med. 2013;45(4):559-561. [CrossRef] [Medline]
    6. Crocheton N, Machet E, Haouache H, Houdart E, Huat G, Claverot J, et al. Screening for carbon monoxide (CO) poisoning by general practitioners in home visits. Presse Med. Feb 2010;39(2):e29-e34. [FREE Full text] [CrossRef] [Medline]
    7. Widdop B. Analysis of carbon monoxide. Ann Clin Biochem. 2002;39(Pt 4):378-391. [CrossRef] [Medline]
    8. Chenoweth JA, Albertson TE, Greer MR. Carbon monoxide poisoning. Crit Care Clin. 2021;37(3):657-672. [CrossRef] [Medline]
    9. Kuisma M, Hiltunen T, Määttä T, Puolakka J, Boyd J, Nousila-Wiik M, et al. Analysis of multiple casualty incidents—a prospective cohort study. Acta Anaesthesiol Scand. 2005;49(10):1527-1533. [CrossRef] [Medline]
    10. Valerio A, Verzè M, Marchiori F, Rucci I, De Santis L, Aprili I, et al. Managing a mass CO poisoning: critical issues and solutions from the field to the hyperbaric chamber. Disaster Med Public Health Prep. 2017;11(2):251-255. [CrossRef] [Medline]
    11. Pasquier M, Dami F, Carron PN, Yersin B, Pignel R, Hugli O. Mass casualty triage in the case of carbon monoxide poisoning: lessons learned. Disaster Med Public Health Prep. 2018;12(3):373-378. [CrossRef] [Medline]
    12. Burney RE, Wu SC, Nemiroff MJ. Mass carbon monoxide poisoning: clinical effects and results of treatment in 184 victims. Ann Emerg Med. 1982;11(8):394-399. [CrossRef] [Medline]
    13. Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology. 1987;66(5):677-679. [FREE Full text] [CrossRef] [Medline]
    14. Barker SJ, Curry J, Redford D, Morgan S. Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study. Anesthesiology. 2006;105(5):892-897. [FREE Full text] [CrossRef] [Medline]
    15. Chan ED, Chan MM, Chan MM. Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respir Med. 2013;107(6):789-799. [FREE Full text] [CrossRef] [Medline]
    16. Piatkowski A, Ulrich D, Grieb G, Pallua N. A new tool for the early diagnosis of carbon monoxide intoxication. Inhal Toxicol. 2009;21(13):1144-1147. [CrossRef] [Medline]
    17. Weaver LK, Churchill SK, Deru K, Cooney D. False positive rate of carbon monoxide saturation by pulse oximetry of emergency department patients. Respir Care. 2013;58(2):232-240. [FREE Full text] [CrossRef] [Medline]
    18. Feiner JR, Rollins MD, Sall JW, Eilers H, Au P, Bickler PE. Accuracy of carboxyhemoglobin detection by pulse CO-oximetry during hypoxemia. Anesth Analg. 2013;117(4):847-858. [FREE Full text] [CrossRef] [Medline]
    19. Bidstrup D, Ravn F, Smidt-Nielsen IG, Wahl AM, Jansen EC, Hyldegaard O. Non-invasive monitoring of carboxyhemoglobin during hyperbaric oxygen therapy. Undersea Hyperb Med. 2021;48(1):33-42. [CrossRef] [Medline]
    20. Suner S, Partridge R, Sucov A, Valente J, Chee K, Hughes A, et al. Non-invasive pulse co-oximetry screening in the emergency department identifies occult carbon monoxide toxicity. J Emerg Med. 2008;34(4):441-450. [CrossRef] [Medline]
    21. Zaouter C, Zavorsky GS. The measurement of carboxyhemoglobin and methemoglobin using a non-invasive pulse CO-oximeter. Respir Physiol Neurobiol. 2012;182(2-3):88-92. [CrossRef] [Medline]
    22. Touger M, Birnbaum A, Wang J, Chou K, Pearson D, Bijur P. Performance of the RAD-57 pulse CO-oximeter compared with standard laboratory carboxyhemoglobin measurement. Ann Emerg Med. 2010;56(4):382-388. [FREE Full text] [CrossRef] [Medline]
    23. Roth D, Herkner H, Schreiber W, Hubmann N, Gamper G, Laggner AN, et al. Accuracy of noninvasive multiwave pulse oximetry compared with carboxyhemoglobin from blood gas analysis in unselected emergency department patients. Ann Emerg Med. 2011;58(1):74-79. [CrossRef] [Medline]
    24. Sebbane M, Claret PG, Mercier G, Lefebvre S, Théry R, Dumont R, et al. Emergency department management of suspected carbon monoxide poisoning: role of pulse CO-oximetry. Respir Care. 2013;58(10):1614-1620. [FREE Full text] [CrossRef] [Medline]
    25. Chee KJ, Nilson D, Partridge R, Hughes A, Suner S, Sucov A, et al. Finding needles in a haystack: a case series of carbon monoxide poisoning detected using new technology in the emergency department. Clin Toxicol (Phila). 2008;46(5):461-469. [FREE Full text] [CrossRef] [Medline]
    26. Bledsoe BE, Nowicki K, Creel JH, Carrison D, Severance HW. Use of pulse co-oximetry as a screening and monitoring tool in mass carbon monoxide poisoning. Prehosp Emerg Care. 2010;14(1):131-133. [CrossRef] [Medline]
    27. Maisel WH, Lewis RJ. Noninvasive measurement of carboxyhemoglobin: how accurate is accurate enough? Ann Emerg Med. 2010;56(4):389-391. [CrossRef] [Medline]
    28. Hampson NB. Noninvasive pulse CO-oximetry expedites evaluation and management of patients with carbon monoxide poisoning. Am J Emerg Med. 2012;30(9):2021-2024. [CrossRef] [Medline]
    29. Daniel Y, Habas S, Cruc M. Prehospital endotracheal intubation in warm climates: caution is required. J Emerg Med. 2016;51(3):262-264. [CrossRef] [Medline]
    30. Weatherall A, Skowno J, Lansdown A, Lupton T, Garner A. Feasibility of cerebral near-infrared spectroscopy monitoring in the pre-hospital environment. Acta Anaesthesiol Scand. 2012;56(2):172-177. [CrossRef] [Medline]
    31. Davis DP, Aguilar S, Sonnleitner C, Cohen M, Jennings M. Latency and loss of pulse oximetry signal with the use of digital probes during prehospital rapid-sequence intubation. Prehosp Emerg Care. 2011;15(1):18-22. [CrossRef] [Medline]
    32. Montenij LJ, de Vries W, Schwarte L, Bierens JJLM. Feasibility of pulse oximetry in the initial prehospital management of victims of drowning: a preliminary study. Resuscitation. 2011;82(9):1235-1238. [FREE Full text] [CrossRef] [Medline]
    33. Kober A, Scheck T, Lieba F, Barker R, Vlach W, Schramm W, et al. The influence of active warming on signal quality of pulse oximetry in prehospital trauma care. Anesth Analg. 2002;95(4):961-966. [FREE Full text] [CrossRef] [Medline]

    ‎
    CO: carbon monoxide
    COHb: carboxyhemoglobin
    ED: emergency department
    O2Hb: oxyhemoglobin
    SpO2: oxygen saturation

    Edited by A Mavragani; submitted 10.04.23; peer-reviewed by A Allonneau; comments to author 25.08.23; revised version received 30.08.23; accepted 31.08.23; published 06.10.23.

    Copyright

    ©Matthieu Lyon, Christophe Alain Fehlmann, Marc Augsburger, Thomas Schaller, Catherine Zimmermann-Ivol, Julien Celi, Birgit Andrea Gartner, Nicolas Lorenzon, François Sarasin, Laurent Suppan. Originally published in JMIR Formative Research (https://formative.jmir.org), 06.10.2023.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.